Cytokine Release Syndrome With Pseudoprogression in a Patient With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.11.025
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer

Current Oncology
Oncology
2019English

Pembrolizumab Combined With Stereotactic Body Radiotherapy in a Patient With Human Immunodeficiency Virus and Advanced Non-Small Cell Lung Cancer: A Case Report

Journal of Medical Case Reports
Medicine
2018English

Pembrolizumab‐induced Secondary Sclerosing Cholangitis in a Non‐small Cell Lung Cancer Patient

Respirology Case Reports
PulmonaryRespiratory Medicine
2020English

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

British Journal of Cancer
Cancer ResearchOncology
2007English

Circadian Function in Patients With Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Modeling Tumor Dynamics and Overall Survival in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Peutz-Jeghers Syndrome Presenting With Non-Small Cell Lung Cancer

MOJ Clinical & Medical Case Reports
2018English

Tracheoesophageal Fistula in a Patient With Advanced Non–Small Cell Lung Cancer Who Received Chemoradiotherapy and Ramucirumab

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Fever and Survival With Drug-Treated Non-Small Cell Lung Cancer.

Kurume Medical Journal
Medicine
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy